Coma after overdose with duloxetine

Annals of Pharmacotherapy

Volumn 45, Issue 1, 2011, Pages

  Kruithof, Maartje K ^a   Bruins, Nynke A ^a   Van Roon, Eric N ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Duloxetine; Overdose poisoning; Serotonin norepinephrine reuptake inhibitor

Indexed keywords

CHARCOAL; DULOXETINE; MAGNESIUM SULFATE;

ADULT; ARTICLE; CASE REPORT; COMA; CONSCIOUSNESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG OVERDOSE; GASTROINTESTINAL ABSORPTION; GLASGOW COMA SCALE; HEMODYNAMICS; HUMAN; INTENSIVE CARE; MALE; ORIENTATION; PRIORITY JOURNAL; SCREENING; URINE RETENTION; WAKEFULNESS;

ADRENERGIC UPTAKE INHIBITORS; COMA; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; OVERDOSE; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TREATMENT OUTCOME; URINARY RETENTION;

EID: 78751502935     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P432     Document Type: Article

References (9)

1. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
2. Position paper: cathartics. J Toxicol Clin Toxicol 2004;42:243-53.
3. Norman TR, Olver JS. Continuation treatment of major depressive disorder: is there a case for duloxetine? Drug Des Devel Ther 2010;4:19-31.
4. Menchetti M, Gozzi BF, Saracino MA, Mercolini L, Petio C, Raggi MA. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines. World J Biol Psychiatry 2009;10:385-9.
5. Dugan SE, Fuller MA. Duloxetine: a dual reuptake inhibitor. Ann Pharmacother 2004;38:2078-85. DOI 10.1345/aph.1E084 (Pubitemid 40169380)
6. Paulzen M. Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt. Int J Neuropsychopharmacol 2009;12:1431-2.
7. Waldschmitt C, Vogel F, Maurer C, Hiemke C. Measurement of duloxetine in blood using high-performance liquid chromatography with spectrophotometric detection and column switching. Ther Drug Monit 2007;29:767-72.
8. Waldschmitt C, Vogel F, Pfuhlmann B, Hiemke C. Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey. Pharmacopsychiatry 2009;42:189-93.
9. Wilson JF. Survey of reference ranges and clinical measurements for psychoactive drugs in serum. Ther Drug Monit 2003;25:243-7.